Search hospitals > North Carolina > Chapel Hill
UNC Lineberger Comprehensive Cancer Center
Claim this profileChapel Hill, North Carolina 27514
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Parotid Gland Cancer
Conducts research for Adult T-Cell Leukemia/Lymphoma
Conducts research for Lymphoma
887 reported clinical trials
71 medical researchers
Summary
UNC Lineberger Comprehensive Cancer Center is a medical facility located in Chapel Hill, North Carolina. This center is recognized for care of Cancer, Breast Cancer, Parotid Gland Cancer, Adult T-Cell Leukemia/Lymphoma, Lymphoma and other specialties. UNC Lineberger Comprehensive Cancer Center is involved with conducting 887 clinical trials across 722 conditions. There are 71 research doctors associated with this hospital, such as Emily Greengard, Stuart H. Gold, David E. Kram, and Jared Weiss, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage III
2Breast Cancer
Global LeaderER positive
Stage IV
HER2 negative
Top PIs
Emily GreengardUniversity of Minnesota/Masonic Cancer Center5 years of reported clinical research
Expert in Cancer
Expert in Neuroblastoma
46 reported clinical trials
74 drugs studied
Stuart H. GoldUNC Lineberger Comprehensive Cancer Center8 years of reported clinical research
Studies Cancer
Studies Neuroblastoma
29 reported clinical trials
74 drugs studied
David E. KramWake Forest University Health Sciences8 years of reported clinical research
Expert in Brain Tumor
Expert in Cancer
29 reported clinical trials
79 drugs studied
Jared Weiss, MDLineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill4 years of reported clinical research
Studies Lung Cancer
Studies Squamous Cell Carcinoma
15 reported clinical trials
33 drugs studied
Clinical Trials running at UNC Lineberger Comprehensive Cancer Center
Breast Cancer
Breast cancer
Kidney Cancer
Bladder Cancer
Parotid Gland Cancer
Ovarian Cancer
Cancer
Pancreatic Cancer
Lung Cancer
Bladder Carcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Low Dose Tamoxifen
for Breast Cancer
This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.
Recruiting2 awards Phase 38 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at UNC Lineberger Comprehensive Cancer Center?
Where is UNC Lineberger Comprehensive Cancer Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does UNC Lineberger Comprehensive Cancer Center accept?
What awards or recognition has UNC Lineberger Comprehensive Cancer Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.